Sutro Logo high res
  • Who We Are
    • About Sutro
    • Leadership
      • Leadership Team
      • Board of Directors
      • Scientific Advisory Board
      • Clinical Advisory Board
    • Collaborations
  • Proprietary Platform
  • Pipeline
    • Overview
    • Scientific Publications
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Financials
    • Stock Data
    • Governance
    • IR Resources
  • Careers
    • The Way We Work
    • DEIB
    • Sustainability
    • Internships
    • Philanthropy
      • Employee Engagement
  • Contact Us

Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting – Poster Presentation

Events, News, Presentations

Society for Immunotherapy of Cancer (SITC) 2025 Annual Meeting – Poster Presentation Next-Generation Immunostimulatory Antibody-Drug Conjugates (iADCs) Combine Tumor Cell Killing with Immune Activation to Induce Durable Antitumor Immunity...

16th Annual World ADC San Diego – Presentations

Events, News, Presentations

16th Annual World ADC San Diego – Presentations Showcasing Development of Site-Specific, High-DAR Dual-Payload ADCs Presenter: Daniel Calarese, Ph.D. Presentation Developing Next-Generation Immunostimulatory Dual Payload ADCs to Enhance Therapeutic Index &...

Sutro R&D Day – Presentation

Events, News, Presentations

Sutro R&D Day – Presentation Presentation...

Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025

Events, News, Presentations, Press Releases

Sutro Biopharma to Host Virtual Research & Development Day on November 12, 2025 SOUTH SAN FRANCISCO, Calif., November 5, 2025 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody...

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference

Events, News, Presentations, Press Releases

Sutro Biopharma Announces Participation at the 16th Annual World ADC Conference SOUTH SAN FRANCISCO, Calif., November 3, 2025 – Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody drug...

21st Annual PEGS Boston Summit – Presentation

Events, News, Presentations

21st Annual PEGS Boston Summit – Presentation...
« Older Entries

Sutro Biopharma

111 Oyster Point Blvd
South San Francisco, CA 94080

Phone: 650-881-6500

Dedicated to patients
and changing the future of oncology

  • Follow
  • Follow
  • Follow
  • Follow

Follow us on social media

© 2026 Sutro Biopharma, Inc.
South San Francisco, California, U.S.A.

SITE MAP | PRIVACY POLICY  | EMAIL ALERTS | CONTACT US | VISITOR GUIDE

 

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Sutro Biopharma, Inc.
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.